Ad is loading...
CMMB
Price
$1.59
Change
-$0.08 (-4.79%)
Updated
Nov 18, 03:16 PM (EDT)
108 days until earnings call
SPRB
Price
$0.48
Change
-$0.01 (-2.04%)
Updated
Nov 18, 03:35 PM (EDT)
114 days until earnings call
Ad is loading...

CMMB vs SPRB

Header iconCMMB vs SPRB Comparison
Open Charts CMMB vs SPRBBanner chart's image
Chemomab Therapeutics
Price$1.59
Change-$0.08 (-4.79%)
Volume$400
CapitalizationN/A
Spruce Biosciences
Price$0.48
Change-$0.01 (-2.04%)
Volume$100
CapitalizationN/A
CMMB vs SPRB Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CMMB vs. SPRB commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and SPRB is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CMMB: $1.67 vs. SPRB: $0.49)
Brand notoriety: CMMB and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 162% vs. SPRB: 70%
Market capitalization -- CMMB: $31.58M vs. SPRB: $20.26M
CMMB [@Biotechnology] is valued at $31.58M. SPRB’s [@Biotechnology] market capitalization is $20.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, CMMB is a better buy in the long-term than SPRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 6 TA indicator(s) are bullish while SPRB’s TA Score has 5 bullish TA indicator(s).

  • CMMB’s TA Score: 6 bullish, 4 bearish.
  • SPRB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CMMB is a better buy in the short-term than SPRB.

Price Growth

CMMB (@Biotechnology) experienced а +13.95% price change this week, while SPRB (@Biotechnology) price change was -8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -6.94%, and the average quarterly price growth was -0.62%.

Reported Earning Dates

CMMB is expected to report earnings on Mar 06, 2025.

SPRB is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMMB($31.6M) has a higher market cap than SPRB($20.3M). CMMB YTD gains are higher at: 228.431 vs. SPRB (-83.256). CMMB has higher annual earnings (EBITDA): -15.97M vs. SPRB (-42.65M). SPRB has more cash in the bank: 69.7M vs. CMMB (12.7M). CMMB has less debt than SPRB: CMMB (360K) vs SPRB (3.69M). SPRB has higher revenues than CMMB: SPRB (9.57M) vs CMMB (0).
CMMBSPRBCMMB / SPRB
Capitalization31.6M20.3M156%
EBITDA-15.97M-42.65M37%
Gain YTD228.431-83.256-274%
P/E RatioN/AN/A-
Revenue09.57M-
Total Cash12.7M69.7M18%
Total Debt360K3.69M10%
TECHNICAL ANALYSIS
Technical Analysis
CMMBSPRB
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMAX1.680.02
+1.20%
CareMax
BY31.14-0.31
-0.99%
Byline Bancorp
APTV52.93-1.10
-2.04%
Aptiv PLC
STXS2.04-0.05
-2.39%
Stereotaxis
DNLI25.05-3.40
-11.95%
Denali Therapeutics

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
-3.74%
AXON - CMMB
37%
Loosely correlated
-0.86%
SPRB - CMMB
36%
Loosely correlated
-5.83%
DSGN - CMMB
30%
Poorly correlated
-3.65%
MDGL - CMMB
29%
Poorly correlated
-4.66%
CNTX - CMMB
28%
Poorly correlated
-3.16%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with MLEC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-5.83%
MLEC - SPRB
51%
Loosely correlated
+0.12%
IMRX - SPRB
49%
Loosely correlated
-7.22%
FATE - SPRB
45%
Loosely correlated
-2.88%
SCPX - SPRB
43%
Loosely correlated
-8.61%
GNFT - SPRB
39%
Loosely correlated
-0.77%
More